Owner ChondroGene Inc.

Inventors Marshall, Wayne, E.; Liew, ChoongChin; Zhang, Hongwei

Agent Wrays

Pub. Number AU-B-2002237124

PCT Pub. Number WO2002/070737

Priority 60/271,955 28.02.01 US; 60/305,340 13.07.01 US; 60/275,017 12.03.01 US

Filing date 28 February 2002

Wipo publication date 19 September 2002

Acceptance publication date 6 March 2008

G01N 33/50 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 19/00 (2006.01) Drugs for skeletal disorders

A61P 19/02 (2006.01) Drugs for skeletal disorders

C12N 1/15 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/19 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/21 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

G01N 33/15 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Medicinal preparations

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay

G01N 37/00 (2006.01) Details not covered by any other group of this subclass